THE CALCULI FORMATION PROPHYLAXIS IN RECURRENT BILATERAL NEPHROLITHIASIS

THE AIM. To evaluate the interrelation between recurrent calculi formation in patients with bilateral nephrolithiasis and the dysfunction in homeostasis system for the pathogenetic correction by fibrinolysis activators and citrate mixtures. PATIENTS AND METHODS. In this study 436 patients with various clinical forms of nephrolithiasis, depending on clinical course, out of whom 110 (25,5%) had one sided renal calculi, 56 (12,8%) were treated regarding urether calculi, 270 (62,0%) had bilateral recurrent renal and urether calculi. The mean age of the patients with nephrolithiasis was 48,6 ± 1,3, in the case of bilateral calculi the mean age of women radically differed from that of men, and if the men’s the mean age was 55,7 ± 2,7, women’s it was 46,1± 2,2. All patents had clinical and special investigations, which let us evaluate the state of hemocoagulation, blood (BFA) and urine (UFA) fibrolitic activity. RESULTS. The conducted study states that hemocoagulation data shows a pronounced increase of the blood coagulating activity in patients with recurrent bilateral nephrolithiasis in comparison with the groups with solitary, firstly revealed concretions of the urinary tract. The more apparent depression of fibrinolysis was noted in the postoperative period. The study of UFA after the operation showed the acute decrease of this index on the 3, 7 and 14 day. For the prophylaxis of the calculi recurrence was used a method, based on the use of citrate mixtures and fibrinolisis activators, which help the lysis of the fibrin in the urinary tract. The results of the BFA investigation in patients receiving the citrates and nicotinic acid showed the increase in its levels by theend of first week after the operation. CONCLUSION. The depression of BFA and UFA during nephrolithiasis pose hazard to the recurrence of the renal concretions. Left in the pelvis and calyx of the kidney the fibrin clots condense and adsorb on their surface the salt crystals, which become a nucleus of recurring concretions. In an effort of metaprophylaxis of recurring nephrolithiasis indicated the means and remedies which increase fibrinolitic behavior of urine and blood.

1. Kavanagh JP. The incidence of calcium oxalate and calcium phosphate cristallyria in urine from non sone formers. 9 th Eur. Symp. on Urolithiasis 2001; 223-224

2. Hesse A, Braendle E, Wilbert D et al. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol2003; 44: 709-713

3. Knoll T, Heger K, Haecker A et al. Percutaneous nephrolithotomy: experience with 348 cases. Eur Urol2004; 2 [Suppl 3]: 13

4. Лопаткин НА, Мартов АГ. Состояние и перспективы развития урологической помощи в Российской Федерации. Мат. Росс. съезда урологов (10) М.; 2002: 5-26

5. Daudon M. Epidemiology of nephrolitiasis in France. Ann Urol (Paris) 2005; 39 (6): 209-231

6. Grosse H. Frequenz, lokalization und Begleiterkrankungen der Harn steine. Analyse von 1671 Urolithiasis – Obduktionen. Z Urol Nephrol 1990; 83 (9): 469-474

7. Pak CYC. Kidney Stone. Lancet1998; 351: 1797-1801

8. Silva JAM, Guerra PG, Raggi P et al. Stone recurrence rate and metaphylaxis in patients underwent extracorporeal shock wave lithotripsy. 10 th Eur. Symp. on Urolithiasis 2002; 279-281

9. Гликин АЭ. Полиминерально – метасоматический кристаллогенез. Изд-во «Журнал Нева», СПб., 2004; 320

10. Chariton СA. Fibrinolysis and Urolithiasis. Lancet 1967;(3): 1199-1200

11. Charlton CA. A urinary detergent and urolithiasis. Brit J Urol 1989; (63): 561-564

12. Hesse A, Siener R. Current aspects of epidemiology and nutrition in urinary stones. World J Urol 1997; (15): 165-171

13. Hesse A, Siener R, Heynck H et al. The influence of dietary factors on the risk of urinary stone formation. Scanning Microsc Int 1993; (7): 1119-1127

14. Зверев ЯФ, Брюханов ВМ, Талалаев ОС и др. О роли процессов свободно-радикального окисления в развитии экспериментального нефролитиаза. Нефрология 2008; 12 (1): 58-63

15. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115(10):2598-2608

16. Tungsanda K, Sriboonlue P, Futrakul P et al. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 2005; 33 (1): 65-69

17. Голощапов ЕТ. Метод определения фибринолитической активности мочи. Лаб дело 1987; (5): 355-356